Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Remodeling of Intrahepatic Ducts in a Model of Caroli Syndrome: Is Scar Carcinoma a Consequence of Laplace's Law?

Chavre BM, Jiang K, St Surin LG, Bissoondial T, Zhou P, Li J, Gadhiya SV, Goldberg ID, Narayan P.

Med Sci (Basel). 2019 Apr 1;7(4). pii: E55. doi: 10.3390/medsci7040055.

2.

Deep Learning in Drug Discovery and Medicine; Scratching the Surface.

Dana D, Gadhiya SV, St Surin LG, Li D, Naaz F, Ali Q, Paka L, Yamin MA, Narayan M, Goldberg ID, Narayan P.

Molecules. 2018 Sep 18;23(9). pii: E2384. doi: 10.3390/molecules23092384. Review.

3.

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease.

Paka P, Huang B, Duan B, Li JS, Zhou P, Paka L, Yamin MA, Friedman SL, Goldberg ID, Narayan P.

World J Nephrol. 2018 Sep 7;7(5):96-107. doi: 10.5527/wjn.v7.i5.96.

4.

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.

Hwang A, Shi C, Zhu E, Naaz F, Zhou P, Rasheed Z, Liu M, Jung LS, Duan B, Li J, Jiang K, Paka L, Gadhiya SV, Dana D, Ali Q, Yamin MA, Goldberg ID, Narayan P.

PLoS One. 2018 Jun 26;13(6):e0198937. doi: 10.1371/journal.pone.0198937. eCollection 2018.

5.

A modified elliptical formula to estimate kidney collagen content in a model of chronic kidney disease.

Nieto JA, Zhu J, Duan B, Li J, Zhou P, Paka L, Yamin MA, Goldberg ID, Narayan P.

PLoS One. 2018 Jan 19;13(1):e0190815. doi: 10.1371/journal.pone.0190815. eCollection 2018.

6.

Kidney Appreciates Stable Blood Pressure.

Patel SN, Narayan P, Goldberg ID, Naaz F, Hussain T, Ali Q.

Am J Hypertens. 2018 Apr 13;31(5):532-533. doi: 10.1093/ajh/hpx212. No abstract available.

7.

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.

Paka L, Smith DE, Jung D, McCormack S, Zhou P, Duan B, Li JS, Shi J, Hao YJ, Jiang K, Yamin M, Goldberg ID, Narayan P.

World J Gastroenterol. 2017 Jun 21;23(23):4181-4190. doi: 10.3748/wjg.v23.i23.4181.

8.

An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.

Nieto JA, Yamin MA, Goldberg ID, Narayan P.

PLoS One. 2016 Oct 3;11(10):e0163063. doi: 10.1371/journal.pone.0163063. eCollection 2016. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0168319.

9.

Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Narayan P, Duan B, Jiang K, Li J, Paka L, Yamin MA, Friedman SL, Weir MR, Goldberg ID.

Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F352-61. doi: 10.1152/ajprenal.00455.2015. Epub 2016 Jun 1.

10.

Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice.

Chaparro RE, Izutsu M, Sasaki T, Sheng H, Zheng Y, Sadeghian H, Qin T, von Bornstadt D, Herisson F, Duan B, Li JS, Jiang K, Pearlstein M, Pearlstein RD, Smith DE, Goldberg ID, Ayata C, Warner DS.

J Cereb Blood Flow Metab. 2015 Jun;35(6):1044-53. doi: 10.1038/jcbfm.2015.23. Epub 2015 Feb 25.

11.

Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.

Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM.

Oncogene. 2007 May 3;26(20):2925-38. Epub 2006 Nov 13.

PMID:
17099727
12.

Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.

Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM.

Anticancer Drugs. 2006 Aug;17(7):733-51.

PMID:
16926624
13.

Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.

Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, Chen Y, Budman D, Goldberg ID, Shi YE.

Breast Cancer Res Treat. 2007 Mar;101(3):259-67. Epub 2006 Jul 4.

PMID:
16821081
14.

Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.

Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM.

Oncogene. 2005 Mar 3;24(10):1749-66.

PMID:
15688034
15.

Structural determinants of the BRCA1 : estrogen receptor interaction.

Ma YX, Tomita Y, Fan S, Wu K, Tong Y, Zhao Z, Song LN, Goldberg ID, Rosen EM.

Oncogene. 2005 Mar 10;24(11):1831-46.

PMID:
15674350
16.

BRCA1 induces antioxidant gene expression and resistance to oxidative stress.

Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM.

Cancer Res. 2004 Nov 1;64(21):7893-909.

18.

BRCA1 inhibition of telomerase activity in cultured cells.

Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM.

Mol Cell Biol. 2003 Dec;23(23):8668-90.

19.

BRCA1 in hormone-responsive cancers.

Rosen EM, Fan S, Pestell RG, Goldberg ID.

Trends Endocrinol Metab. 2003 Oct;14(8):378-85. Review.

PMID:
14516936
20.

Induction of mammary gland differentiation in transgenic mice by the fatty acid-binding protein MRG.

Wang M, Liu YE, Goldberg ID, Shi YE.

J Biol Chem. 2003 Nov 21;278(47):47319-25. Epub 2003 Sep 15.

21.

Stimulation of estrogen receptor signaling by gamma synuclein.

Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J, Shi YE.

Cancer Res. 2003 Jul 15;63(14):3899-903.

22.

Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP.

Jeon KI, Rih JK, Kim HJ, Lee YJ, Cho CH, Goldberg ID, Rosen EM, Bae I.

FEBS Lett. 2003 Jun 5;544(1-3):246-51.

23.

BRCA1 gene in breast cancer.

Rosen EM, Fan S, Pestell RG, Goldberg ID.

J Cell Physiol. 2003 Jul;196(1):19-41. Review.

PMID:
12767038
24.

BRCA1 is differentially expressed in human tumor cells.

Meng QH, Yuan RQ, Goldberg ID, Rosen EM, Fan SJ.

Shi Yan Sheng Wu Xue Bao. 2001 Mar;34(1):55-64.

PMID:
12549011
25.

Role of BRCA1 in heat shock response.

Xian Ma Y, Fan S, Xiong J, Yuan RQ, Meng Q, Gao M, Goldberg ID, Fuqua SA, Pestell RG, Rosen EM.

Oncogene. 2003 Jan 9;22(1):10-27.

PMID:
12527903
26.

Complex roles of tissue inhibitors of metalloproteinases in cancer.

Jiang Y, Goldberg ID, Shi YE.

Oncogene. 2002 Mar 28;21(14):2245-52. Review.

27.

p300 Modulates the BRCA1 inhibition of estrogen receptor activity.

Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM.

Cancer Res. 2002 Jan 1;62(1):141-51.

28.

Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.

Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID, Rosen EM.

Oncogene. 2001 Dec 13;20(57):8215-35.

29.
30.

Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells.

Gao M, Fan S, Goldberg ID, Laterra J, Kitsis RN, Rosen EM.

J Biol Chem. 2001 Dec 14;276(50):47257-65. Epub 2001 Sep 24.

31.

Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding.

Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM.

Oncogene. 2001 Aug 9;20(35):4827-41.

32.

Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA.

Celiker MY, Wang M, Atsidaftos E, Liu X, Liu YE, Jiang Y, Valderrama E, Goldberg ID, Shi YE.

Oncogene. 2001 Jul 19;20(32):4337-43.

PMID:
11466614
33.

The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.

Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM.

Mol Cell Biol. 2001 Aug;21(15):4968-84.

34.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
35.

Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery.

Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, Shi YE.

Cancer Res. 2001 Mar 15;61(6):2365-70.

36.

P53-independent downregulation of p73 in human cancer cells treated with Adriamycin.

Yuan R, Meng Q, Hu H, Goldberg ID, Rosen EM, Fan S.

Cancer Chemother Pharmacol. 2001;47(2):161-9.

PMID:
11269743
37.

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.

Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM.

Oncogene. 2001 Jan 4;20(1):77-87.

38.

Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.

Meng Q, Xu J, Goldberg ID, Rosen EM, Greenwald RA, Fan S.

Clin Exp Metastasis. 2000;18(2):139-46.

PMID:
11235989
39.

Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.

Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, Fan S.

FEBS Lett. 2001 Jan 19;488(3):179-84.

40.

Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.

Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S.

J Nutr. 2000 Dec;130(12):2927-31.

PMID:
11110848
42.

Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells.

Meng Q, Goldberg ID, Rosen EM, Fan S.

Breast Cancer Res Treat. 2000 Sep;63(2):147-52.

PMID:
11097090
43.

Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines.

Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, Rosen EM.

Cancer Res. 2000 Oct 15;60(20):5635-9.

44.
45.

Hepatocyte growth factor decreases sensitivity to chemotherapeutic agents and stimulates cell adhesion, invasion, and migration.

Meng Q, Mason JM, Porti D, Goldberg ID, Rosen EM, Fan S.

Biochem Biophys Res Commun. 2000 Aug 11;274(3):772-9.

PMID:
10924353
46.

Stimulation of cell invasion and migration by alcohol in breast cancer cells.

Meng Q, Gao B, Goldberg ID, Rosen EM, Fan S.

Biochem Biophys Res Commun. 2000 Jul 5;273(2):448-53.

PMID:
10873626
47.

Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.

Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen EM, Auborn K, Fan S.

J Mol Med (Berl). 2000;78(3):155-65.

PMID:
10868478
48.

Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.

Rosen EM, Fan S, Goldberg ID, Rockwell S.

Oncology (Williston Park). 2000 May;14(5):741-57; discussion 757-8, 761-6. Review.

49.

Biological basis of radiation sensitivity. Part 1: Factors governing radiation tolerance.

Rosen EM, Fan S, Goldberg ID, Rockwell S.

Oncology (Williston Park). 2000 Apr;14(4):543-50. Review.

50.

Supplemental Content

Loading ...
Support Center